ArticleInternational journal of clinical oncology2022

Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma.

Liudmila V Fedorova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.